Gates Foundation Pledges $2.5B for Women's Health R&D

The Gates Foundation has announced a $2.5 billion commitment over five years to advance research and development in women's health, focusing on maternal, menstrual, gynecological, and sexual health, especially in low- and middle-income countries. Around 60% of the funds will target obstetrics and maternal health, with a focus on technologies like AI-powered ultrasounds and discreet long-acting contraceptives. The initiative aims to support over 40 innovations addressing conditions such as preeclampsia, endometriosis, and improving contraception and maternal care. Currently, only 1% of healthcare R&D funding addresses female-specific issues outside oncology. The Foundation is calling on governments, philanthropists, and the private sector to co-invest, emphasizing that much more funding is needed. Leaders assert that the effort seeks to close care gaps, prioritize women’s needs, and ensure equitable access to treatments globally.